Newsroom

Learn more about us in our featured news stories and insights into our work

News Press Releases Locus Insights

April 25, 2021

It’s DNA Day! Here Are 4 Ways Gene Editing Is Transforming Medicine

Learn More
March 8, 2021

New clinical trial data from Locus Biosciences shows promise in CRISPR-Cas3 technology

Learn More
March 5, 2021

Could this Research Triangle Park company hold a key to fighting drug-resistant bacteria?

Learn More
February 24, 2021

Locus Biosciences completes first-of-its-kind controlled clinical trial for CRISPR-enhanced bacteriophage therapy

Learn More
February 24, 2021

Genetically enhanced antibiotic from RTP firm advances in first-of-its-kind clinical trial

Learn More
December 17, 2020

Gene editing success could turn Triangle startup Locus Biosciences into a billion dollar unicorn

Learn More
November 10, 2020

Locus Biosciences signs contract with CARB-X to advance $14 million precision medicine program to develop crPhage™ product targeting Klebsiella pneumoniae infections

Learn More
September 30, 2020

Locus Biosciences signs contract with BARDA to advance $144 million precision medicine program to develop LBP-EC01, a crPhage™ product

Learn More
August 3, 2020

CRISPR Startups Give Genome Editing Several New Twists

Learn More
June 29, 2020

The First Controlled Clinical Trial For A CRISPR Enhanced Bacteriophage Therapy

Learn More